Ahmed Aboulenein,a reuters correspondent based in Washington,D.C., specializes in U.S. healthcare and pharmaceutical policy. His reporting often centers on the Department of Health and Human Services and its associated agencies, including the Food and Drug Governance. Prior too his current role, Aboulenein was stationed in Iraq and Egypt.
Aboulenein’s work contributes to Reuters’ coverage of critical policy developments impacting the healthcare sector. His expertise in this area provides readers with in-depth analysis of regulatory changes, legislative initiatives, and the broader landscape of health and pharmaceutical policy in the United States.